首页> 外文学位 >Structural elucidation and dynamic studies of MO tripeptide diastereomers (M = technetium-99m, technetium-99, rhenium): An extension to targeted radiopharmaceuticals.
【24h】

Structural elucidation and dynamic studies of MO tripeptide diastereomers (M = technetium-99m, technetium-99, rhenium): An extension to targeted radiopharmaceuticals.

机译:MO三肽非对映异构体的结构阐明和动力学研究(M = net- 99m,tech-99,rh):对靶向放射性药物的扩展。

获取原文
获取原文并翻译 | 示例

摘要

Neotect(TM) (99mTc depreotide), the first targeted radiopharmaceutical that entered clinical use as imaging agent for lung tumors, consisted of two species that were purportedly identified as syn and anti diastereomers based on NMR, mass spec, and IR data. Because their biological behaviors are significantly different, it was critical to obtain the absolute identity for each diastereomer. This dissertation has accomplished this goal using [MV=O] tripeptide diastereomers. Moreover, since the identification of these diastereomers is general for all 99mTc tripeptide (comprised of L amino acids) complexes, this information will aid in the identification of the 99mTc and 188Re radiopharmaceuticals when the [M=O]+3 core in a tripeptide binding site is employed.; We isolated 99Tc and Re diastereomers of several tripeptide ligands, including three (MKC, FKC, and YKC) that closely model 99m Tc depreotide. Using X-ray crystallography, we show that, as expected, the TcO is bound to the ligand in a square pyramidal coordination environment. The crystallography demonstrated that the early eluting peak (A) corresponds to the "anti" diastereomer where the Tc=O group is on the opposite side of the square plane formed by the ligand backbone relative to the pendant groups of the tripeptide ligand, and the later eluting peak (B) corresponds to the "syn" diastereomer, where the Tc=O group is on the same side of the plane as the residues of the tripeptide. Moreover, 1H NMR and circular dichroism spectroscopy confirm that the 99/99mTc tripeptide models have the same diastereomer profile as 99/99mTc depreotide.; Observations made during the syntheses of 99Tc and Re diastereomers provided hypotheses for the stability of diastereomers. Stability of diastereomers was addressed by quantitative kinetic studies of the interconversion of the 99mTc analogs. We postulate that hydrogen bonding of residues, for example the epsilonNH3 of lysine with the -yl oxygen of the Tc/Re=O or with a carbonyl of the tripeptide in syn complexes, may be a stabilizing force. Also, the potential hydrogen bonding of the Tc=O with the C-terminal amide appears to be a stabilizing factor in MO FGC anti (M=Tc,Re) according to experimental kinetic studies and preliminary DFT calculations.
机译:Neotect TM(99mTc depreotide)是第一种进入临床用作肺肿瘤显像剂的靶向放射性药物,据称根据NMR,质谱和IR数据被鉴定为顺反非对映异构体两种。由于它们的生物学行为明显不同,因此获得每种非对映异构体的绝对身份至关重要。本文利用[MV = O]三肽非对映异构体实现了这一目标。此外,由于这些非对映异构体的鉴定对于所有99mTc三肽(由L个氨基酸组成)复合物都是通用的,因此,当三肽结合中的[M = O] +3核心时,此信息将有助于鉴定99mTc和188Re放射性药物。场地被雇用。我们分离了几种三肽配体的99Tc和Re非对映异构体,包括三个与99m Tc降丙肽密切相关的MKC,FKC和YKC。使用X射线晶体学,我们证明了,正如预期的那样,TcO在方形金字塔配位环境中与配体结合。晶体学表明,早期洗脱峰(A)对应于“反”非对映异构体,其中Tc = O基团相对于三肽配体的侧基在配体主链形成的方平面的相对侧,并且随后的洗脱峰(B)对应于“ syn”非对映异构体,其中Tc = O基团与三肽残基在平面的同一侧。此外,1 H NMR和圆二色性光谱证实了99 / 99mTc三肽模型具有与99 / 99mTc depreotide相同的非对映异构体谱。在合成99Tc和Re非对映异构体期间所做的观察为非对映异构体的稳定性提供了假设。非对映异构体的稳定性通过99mTc类似物相互转化的定量动力学研究解决。我们假设残基的氢键,例如赖氨酸的εNH3与Tc / Re = O的-基氧或三肽在顺式配合物中的羰基键合可能是稳定力。同样,根据实验动力学研究和初步的DFT计算,Tc = O与C端酰胺的潜在氢键似乎是MO FGC抗(M = Tc,Re)的稳定因子。

著录项

  • 作者

    Cantorias, Melchor V.;

  • 作者单位

    City University of New York.;

  • 授予单位 City University of New York.;
  • 学科 Chemistry Inorganic.; Chemistry Pharmaceutical.; Chemistry Nuclear.
  • 学位 Ph.D.
  • 年度 2006
  • 页码 265 p.
  • 总页数 265
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 无机化学;药物化学;无机化学;
  • 关键词

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号